{"schema_version":"alpha-profile-public-v1","slug":"alan-a-musso","canonical_url":"https://registry.alpha.ac/people/alan-a-musso","as_of":"2026-09-22T17:52:23.01803+00:00","published_at":"2026-09-02T02:37:19.86623+00:00","last_reviewed_at":"2026-05-16T02:17:29.609+00:00","identity":{"display_name":"Alan A. Musso","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Rein Therapeutics, Inc.","company_slug":"rein-therapeutics-inc","exchange":"NASDAQ","ticker":"RNTX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","effective_date":"2025-05-12","last_checked_at":"2026-04-28T23:20:02.101+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=alan-a-musso","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=alan-a-musso&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Alan A. Musso has served as chief financial officer of Fulcrum Therapeutics since August 2023. He previously served as chief financial officer of ReViral Ltd. from October 2019 to September 2022, Peloton Therapeutics Inc. from September 2018 to September 2019, and Bellicum Pharmaceuticals, Inc. from November 2014 to August 2018. He has extensive experience in biopharmaceutical finance and served as a CPA and senior internal auditor."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Rein Therapeutics, Inc.","organizationId":"rein-therapeutics-inc","title":"Director","period":"2023-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Rein Therapeutics, Inc.","company_slug":"rein-therapeutics-inc","exchange":"NASDAQ","ticker":"RNTX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","effective_date":"2025-05-12","last_checked_at":"2026-04-28T23:20:02.101+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Alan A. Musso as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:17:29.816883+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RNTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","published_at":"2025-05-12T00:00:00+00:00","last_checked_at":"2026-05-16T02:17:29.685547+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Alan A. Musso currently serves as Director at Rein Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-05-12","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:17:29.773576+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RNTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","published_at":"2025-05-12T00:00:00+00:00","last_checked_at":"2026-05-16T02:17:29.685547+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"Alan A. Musso serves on Audit, Compensation.","claim_state":"verified","valid_from":"2025-05-12","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:17:29.795013+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RNTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","published_at":"2025-05-12T00:00:00+00:00","last_checked_at":"2026-05-16T02:17:29.685547+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Fulcrum Therapeutics","claim_text":"Alan A. Musso is linked to Fulcrum Therapeutics as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:17:29.990396+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RNTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","published_at":"2025-05-12T00:00:00+00:00","last_checked_at":"2026-05-16T02:17:29.685547+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Financial Officer","claim_text":"Alan A. Musso is also listed as Chief Financial Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:17:29.953057+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RNTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","published_at":"2025-05-12T00:00:00+00:00","last_checked_at":"2026-05-16T02:17:29.685547+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Alan A. Musso as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:17:29.862053+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RNTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","published_at":"2025-05-12T00:00:00+00:00","last_checked_at":"2026-05-16T02:17:29.685547+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Alan A. Musso as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:17:29.8394+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RNTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","published_at":"2025-05-12T00:00:00+00:00","last_checked_at":"2026-05-16T02:17:29.685547+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:alan-a-musso","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2023-01-01 · current","organization":"Rein Therapeutics, Inc.","organization_id":"rein-therapeutics-inc"},"claim_text":"Director at Rein Therapeutics, Inc. (2023-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/alan-a-musso#profile","url":"https://registry.alpha.ac/people/alan-a-musso","dateModified":"2026-05-16T02:17:29.609+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/alan-a-musso#person","name":"Alan A. Musso","url":"https://registry.alpha.ac/people/alan-a-musso","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Rein Therapeutics, Inc.","tickerSymbol":"NASDAQ: RNTX"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","memberOf":{"@type":"Organization","name":"Rein Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/rein-therapeutics-inc","tickerSymbol":"NASDAQ: RNTX"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm","name":"RNTX DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/alan-a-musso"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T02:17:29.609+00:00","observed_at":"2026-09-22T17:52:23.01803+00:00","freshness_days":130}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"alan-a-musso","canonical_url":"https://registry.alpha.ac/people/alan-a-musso"},"publication":{"published_at":"2026-09-02T02:37:19.86623+00:00","last_reviewed_at":"2026-05-16T02:17:29.609+00:00","as_of":"2026-09-22T17:52:23.01803+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/alan-a-musso","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/alan-a-musso","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/alan-a-musso.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}